ATTR-CM

Real-world evidence

The information is provided for educational and scientific exchange purposes, and does not suggest products should be used in a manner not consistent with their respective label approved by the regulatory authorities, which may differ by geography. Any publication reflects the state of knowledge at the time it was published. The information is not medical advice and cannot replace the independent medical judgement of a healthcare professional.

Featured • New real-world comparative effectiveness data

Comparative Effectiveness of TTR Stabilizers for the Treatment of ATTR-CM Using Real-World Evidence

First author Wright R, et al

September 2026

Journal: Springer Nature

This publication includes information, analysis and results that are not included in the FDA-approved Prescribing Information for acoramidis. A head-to-head study of acoramidis and tafamidis has not been conducted.

Journal Link